ChromaDex Q3 EPS $0.02 Up From $(0.01) YoY, Sales $25.58M Beat $23.64M Estimate
Portfolio Pulse from Benzinga Newsdesk
ChromaDex (NASDAQ:CDXC) reported a significant improvement in its Q3 earnings, with EPS rising to $0.02 from a loss of $(0.01) last year. Sales also exceeded expectations, reaching $25.58 million, an 8.21% beat over the $23.64 million estimate and a 31.21% increase from the previous year.
October 31, 2024 | 8:06 pm
News sentiment analysis
Sort by:
Ascending
POSITIVE IMPACT
ChromaDex's Q3 earnings report shows a strong performance with EPS of $0.02, a 300% increase from last year, and sales of $25.58 million, beating estimates by 8.21%.
The significant improvement in EPS from a loss to a profit and the sales beat indicate strong financial performance, likely boosting investor confidence and positively impacting the stock price in the short term.
CONFIDENCE 95
IMPORTANCE 90
RELEVANCE 100